Radiopharm Theranostics (ASX:RAD) has announced positive Phase 1 imaging data for its pancreatic cancer candidate, RAD301. The study showed a favorable safety profile and significant, selective tumor uptake in pancreatic cancer metastases, with low background uptake in normal tissues. These promising results support advancing RAD301 into a Phase 2 clinical trial, indicating its potential for improved pancreatic cancer detection and patient selection.

Latigo Biotherapeutics' (NASDAQ:LTGO) quiet period is set to expire on September 16th, potentially allowing IPO underwriters to issue research coverage after its $345.6 million offering. Analyst sentiment is largely positive, with a consensus "Buy" rating and an average price target of $52.25, though one firm downgraded it to "Sell." Insider transactions show significant share purchases by Director James B. Tananbaum and Foresite Capital at the IPO price.

Arch Capital Group Ltd. (NASDAQ:ACGL) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $111.11. The company recently reported strong quarterly results, beating EPS and revenue expectations. Despite this, the stock opened down 2.4%, and its CFO recently sold over $1 million worth of shares.

Radiopharm Theranostics has reported encouraging early results from a Phase 1 imaging trial of its experimental agent RAD301 for pancreatic ductal adenocarcinoma. The trial showed a favorable safety profile and significant tumor uptake, supporting RAD301's potential as both a diagnostic and therapeutic tool. The agent targets αvβ6 integrin, a marker strongly associated with tumor invasion, and showed low background signal in organs where pancreatic cancer commonly metastasizes, aiding in more accurate staging and monitoring.

Allworth Financial LP significantly reduced its stake in Verizon Communications Inc. (NYSE:VZ) by 29.4% during the second quarter, selling 148,888 shares and ending with holdings worth $15.165 million. Despite this, other institutional investors like California State Teachers Retirement System and Norges Bank substantially increased their positions in Verizon. The article also provides a financial overview of Verizon, including recent earnings, analyst ratings, and insider trading activity, highlighting the company's strong market position and recent strategic agreements.

Amundi reduced its stake in Crown Castle Inc. (NYSE:CCI) by 9.2% during the second quarter, selling 180,465 shares, although it still holds over 1.7 million shares valued at $134.6 million. Meanwhile, other institutional investors like California State Teachers Retirement System, BlackRock Inc., and Norges Bank significantly increased their holdings in Crown Castle. The article also provides a financial overview of Crown Castle, including its market cap, P/E ratio, recent earnings, dividend announcement, and analyst ratings, alongside details of an insider stock sale by VP Robert Collins.

Amundi reduced its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 20.2% in the second quarter, selling 373,876 shares and retaining 1,473,876 shares valued at $142.79 million. Other hedge funds also adjusted their positions, and company insiders sold a significant number of shares recently. Analysts have issued various ratings and price targets, with the stock currently having a "Hold" consensus target of $104.41.

Amundi increased its stake in Ball Corporation (NYSE:BALL) by 131.8% in the second quarter, acquiring an additional 1,461,375 shares to hold a total of 2,570,458 shares worth $160.4 million. Other large institutional investors like California State Teachers Retirement System and BlackRock Inc. also significantly boosted their holdings. Ball Corporation reported strong Q2 earnings, beating analyst estimates, and declared a quarterly dividend of $0.20 per share.

Amundi increased its stake in Las Vegas Sands Corp. (NYSE:LVS) by 14.5% during the second quarter, now holding 3,281,533 shares valued at $151.57 million. Other institutional investors like California State Teachers Retirement System and AQR Capital Management LLC also significantly increased their positions. The article also details recent analyst ratings for LVS, its stock performance, and dividend information, noting that the stock has an average rating of "Hold" with an average price target of $61.88.

Amundi increased its stake in Iron Mountain Incorporated (NYSE:IRM) by 7.0% during the second quarter, bringing its total holdings to 1,168,430 shares valued at $147.58 million. This move is part of a broader trend of institutional investment in Iron Mountain, with several other hedge funds also adjusting their positions. The company recently reported strong Q2 earnings, beating analyst estimates, and announced a quarterly dividend of $0.864 per share.